Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmacia To Publish Full 12-Month Data From CLASS Study Of Celebrex

Executive Summary

Pharmacia is preparing to publish the full 12-month data from the Celebrex CLASS GI outcomes study.

You may also be interested in...



Conflict of Interest Policy Limits Industry Control Over Studies, Publication

Sponsors will have a limited time to review manuscripts before publication, a revised conflict of interest policy from the major medical journals states.

Conflict of Interest Policy Limits Industry Control Over Studies, Publication

Sponsors will have a limited time to review manuscripts before publication, a revised conflict of interest policy from the major medical journals states.

Journals' conflict of interest policy

Revised International Committee of Medical Journal Editors' conflict of interest policy, to be published in 10 journals the week of Sept. 10, urges increased author independence and accountability for publications (1"The Pink Sheet" Aug. 20, p. 8)

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS038375

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel